April, 2021

article thumbnail

UK Vaccine Taskforce head lifts lid on Novavax deal

pharmaphorum

The UK’s unique offering as a life sciences research hub helped convince US biotech Novavax to develop its COVID-19 jab there, according to the head of the country’s Vaccines Taskforce. . Last August the UK government finalised a deal with Novavax to purchase 60 million doses of the NVX-CoV2373 vaccine, which will also be manufactured in the country at a plant owned by FUJIFILM Diosynth Biotechnologies in Stockton-on-Tees.

Vaccines 141
article thumbnail

Millions Are Skipping Their Second Doses of Covid Vaccines

NY Times

Nearly 8 percent of those who got initial Pfizer or Moderna shots missed their second doses. State officials want to prevent the numbers from rising.

Vaccines 144
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Take the next step into CROY 2021

Pharma Times

The 2021 Clinical Researcher of the Year – The Americas competition is reaching out to the very best in the industry to take the next step and claim gold.

122
122
article thumbnail

Thermo Fisher Scientific snaps up PPD in $17.4b acquisition deal

Outsourcing Pharma

The science service and technologies firm plans to bring the CRO under its Laboratory Products and Services Segment umbrella after the deal is completed.

115
115
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Introducing the 2020-21 HBA Honorable Mentor and STAR Awardees

Pharma Marketing Network

Introducing the recipient of the 2020-21 HBA Honorable Mentor Award, Dr. Rod MacKenzie , Chief Development Officer and EVP, Pfizer and the recipient of the 2020-21 HBA STAR Award, Susan Torroella , Chief Operating Officer, ArmadaHealth. What is the Honorable Mentor Award? The Honorable Mentor award recognizes a man who demonstrates a long-term commitment to advancing women in the workforce, is dedicated to developing, mentoring and promoting women in the industry, and is supportive of the overal

98
article thumbnail

New patent for Vanda Pharms drug HETLIOZ

Drug Patent Watch

Annual Drug Patent Expirations for HETLIOZ Hetlioz is a drug marketed by Vanda Pharms Inc and is included in two NDAs. It is available from one supplier. There are fifteen…. The post New patent for Vanda Pharms drug HETLIOZ appeared first on DrugPatentWatch - Make Better Decisions.

98

More Trending

article thumbnail

Vaccines Won’t Protect Millions of Patients With Weakened Immune Systems

NY Times

Many cannot produce enough infection-fighting cells to fend off the coronavirus. But researchers are testing one therapy that may help: monoclonal antibodies.

Immunity 130
article thumbnail

Amylyx Pharma plans to file ALS therapy with the EMA this year

Pharma Times

The previously-reported CENTAUR study of AMX0035 in 137 participants with ALS met its primary endpoint of slowing ALS progression

123
123
article thumbnail

Canine cancer research startup impacts treatment in humans

Outsourcing Pharma

One Healthâs FidoCure is using genomics and AI technology to develop precision oncological treatments, and the work is benefiting human cancer research.

112
112
article thumbnail

6 Digital Tools at the Center of Healthcare Digitalization [INFOGRAPHIC]

Pharma Marketing Network

Over the last year, we witnessed a massive shift to digital technologies in the health industry – trends that were gradually making their ways suddenly moved into prompt adoption due to the immense limitations brought by the COVID-19 pandemic. Download this infographic and learn which 6 digital tools are at the center of digitalization and how the will influence the future of Pharma marketing in 2021 and beyond.

article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Proposed amendments to the PM(NOC) Regulations: Patents claiming different salt forms of medicinal ingredients eligible for inclusion on the Patent Register

Pharma in Brief

On April 23, 2021, Proposed PM(NOC) Amendments [1] were published in the Canada Gazette, Part I. These amendments permit patents claiming different forms of a medicinal ingredient (e.g., salt forms) to be listed on the patent register and are intended to balance Proposed FDR Amendments [2] published on March 30, 2019 which allow generic manufacturers to file an ANDS for an alternative form of a medicinal ingredient in comparison to the CRP.

98
article thumbnail

Apple, Google block NHS contact tracing app update on privacy grounds

pharmaphorum

A scheduled update to the NHS COVID-19 app has been blocked because it allows location tracking – something prohibited by Apple and Google, which developed some of the code it uses. . The new version of the app used in England and Wales was due to become available today to coincide with the relaxation of lockdown rules, with the public now able to attend venues such as non-essential shops, pub beer garden, gyms and hairdressers.

138
138
article thumbnail

New patent for Pharmacyclics Inc drug IMBRUVICA

Drug Patent Watch

Annual Drug Patent Expirations for IMBRUVICA Imbruvica is a drug marketed by Pharmacyclics Inc and is included in two NDAs. It is available from one supplier. There are thirty-nine patents…. The post New patent for Pharmacyclics Inc drug IMBRUVICA appeared first on DrugPatentWatch - Make Better Decisions.

97
article thumbnail

Magic mushroom compound psilocybin shows ‘promise’ in depression

Pharma Times

Researchers from Imperial College London say compound is at least as effective as a leading antidepressant in a therapeutic setting

article thumbnail

Researchers Are Hatching a Low-Cost Coronavirus Vaccine

NY Times

A new formulation entering clinical trials in Brazil, Mexico, Thailand and Vietnam could change how the world fights the pandemic.

Vaccines 115
article thumbnail

Protected: Health Psychology – the Solution to First Fill Abandonment?

Pharma Marketing Network

This content is password protected. To view it please enter your password below: Password: The post Protected: Health Psychology – the Solution to First Fill Abandonment? appeared first on Pharma Marketing Network.

96
article thumbnail

Berg taps into supercomputer to battle COVID-19 variants

Outsourcing Pharma

The advanced biotech analysis company is harnessing the power of a formidable supercomputer to discover potential treatments for the virus and mutations.

98
article thumbnail

Is disability the last bastion of the representation debate?

pharmaphorum

From #MeToo to Black Lives Matter, as a society we have been discussing the relationship between representation and equality more than ever over the last few years. . But while progress is being made in so many areas, people with disabilities are still struggling to find a voice above the accepted narrative, says Ross Lannon, the 27-year-old blogger and multi-media content creator behind A Life on Wheels.

article thumbnail

Stop paying your staff to make repetitive reports

Drug Patent Watch

How Much Time Are You Wasting on Manual, Repetitive Tasks? Stop wasting time on repetitive reports: Contact us Are your staff burdened with manual, repetitive tasks, like data collection, and…. The post Stop paying your staff to make repetitive reports appeared first on DrugPatentWatch - Make Better Decisions.

77
article thumbnail

Calling all pharma marketers

Pharma Times

The 2021 Marketer of the Year competition is well underway for entries and is looking for the best and brightest to join the ranks.

114
114
article thumbnail

How Europe Sealed a Pfizer Vaccine Deal With Texts and Calls

NY Times

The European Union is about to sign a deal for 1.8 billion doses of the Pfizer-BioNTech vaccine after a dispute with AstraZeneca derailed its vaccination campaign. Here’s how it came about.

article thumbnail

DarshanTalks: Sales & Marketing Oversight – April 21, 2021

Pharma Marketing Network

[link]. The Pharma Marketing Podcast is pleased to present this special guest episode from our friend and Editorial Advisory Board member Darshan Kulkarni, Sales and Marketing Oversight – April 21, 2021. Darshan Kulkarni and Marc Banjak, General Counsel at Dova Pharmaceuticals, discuss sales compliance in the life sciences. Sales and marketing representatives in the life science industry must comply with state and federal regulations.

90
article thumbnail

Cyclica teams with academics to investigate COVID-19 treatment

Outsourcing Pharma

The drug-discovery firm has partnered with several academic institutions to explore a Novartis lung-cancer treatmentâs potential in treating COVID-19.

95
article thumbnail

Digital tool will be tested against COVID-19 ‘brain fog’

pharmaphorum

A digital tool used to treat attention-deficit hyperactivity disorder (ADHD) is being tested to see if it can help counter lingering, fuzzy thinking in COVID-19 survivors, a condition sometimes known as ‘brain fog’ An app called EndeavorRx – developed by PureTech Health-backed Akili Interactive – will be tested in two clinical trials to see if it can improve cognitive function in people who have recovered from COVID-19 but still show cognitive problems weeks or months later.

Hospitals 126
article thumbnail

New patent for NOVO drug RYBELSUS

Drug Patent Watch

Annual Drug Patent Expirations for RYBELSUS Rybelsus is a drug marketed by Novo and is included in one NDA. It is available from one supplier. There are five patents protecting…. The post New patent for NOVO drug RYBELSUS appeared first on DrugPatentWatch - Make Better Decisions.

69
article thumbnail

Nationwide launch for pioneering fertility study

Pharma Times

The NIHR-funded trial will assess whether removing small fibroids and endometrial polyps improves fertility and live births

117
117
article thumbnail

Vaccines Won’t Protect Millions of Patients With Crippled Immune Systems

NY Times

Many cannot produce enough infection-fighting cells to fend off the coronavirus. But researchers are testing one therapy that may help: monoclonal antibodies.

article thumbnail

Key Sessions From the AI in Healthcare Virtual Summit

Pharma Marketing Network

The AI in Healthcare Virtual Summit focused on AI methods and tools that are set to transform healthcare, medicine, and diagnostics along with the latest applications within the industry. . Here are some key sessions during the summit that discussed machine learning for antibiotic discovery, creating personalized neuro medicine using AI and brain modelling, and deep learning for biomedical imaging.

article thumbnail

Study explores synthetic cannabinoid for cancer-related anorexia

Outsourcing Pharma

Artelo Biosciences is investigating the viability of its novel cannabinoid product as a solution to treat cancer-related anorexia in oncology patients.

91
article thumbnail

Jolly Good/Teijin Pharma develop VR digital therapeutics for depression

pharmaphorum

Technology firm Jolly Good and Teijin Pharma have begun a partnership to develop virtual reality digital therapeutics (VR DTx) for major depressive disorder. The goal of the partnership for approval for the Japanese market from the Pharmaceuticals and Medical Devices Agency (PMDA). Jolly Good has already won a “Home Healthcare Award” in a programme held by Teijin in December last year.

Hospitals 120
article thumbnail

New patent for Horizon Pharma drug PROCYSBI

Drug Patent Watch

Annual Drug Patent Expirations for PROCYSBI Procysbi is a drug marketed by Horizon Pharma Usa and is included in two NDAs. There are sixteen patents protecting this drug. Drug patent…. The post New patent for Horizon Pharma drug PROCYSBI appeared first on DrugPatentWatch - Make Better Decisions.

59
article thumbnail

Pfizer, Myovant begin dosing in relugolix contraceptive study

Pharma Times

Dosing has begun in a Phase III study evaluating the contraceptive efficacy of relugolix combination tablet

122
122
article thumbnail

Researchers Are Hatching a Low-Cost Covid-19 Vaccine

NY Times

A new formulation entering clinical trials in Brazil, Mexico, Thailand and Vietnam could change how the world fights the pandemic.

Vaccines 105
article thumbnail

Tune In: Key Learnings and Insights from Leaders in Native Advertising

Pharma Marketing Network

Native advertising may mean something different to you depending on what part of the industry you’re in whether it be in advertising or publishing. . Tune in and listen to the Pharma Marketing Network and fellow thought leaders from, ROI Marketplace, MedThink, and Sharecare.com, discuss their learnings and insights on native advertising from each of their respective vantage points – pharma-marketer, publisher, and agency. .

article thumbnail

Charles River, Valence Discovery partner on AI-aided drug design

Outsourcing Pharma

The collaboration will enable Charles River clients to access Valenceâs artificial intelligence platform in their pharmaceutical development projects.

91